Synthetic ‘kill switch’ could fast track new immunotherapies, turning bacterial armies against cancer tumours, study shows.
Will this Chinese-engineered ‘bacterial assassin’ transform cancer treatment?

RELATED ARTICLES
Mar 16, 2025 | EARNINGS
Mar 16, 2025 | INVESTING
Mar 16, 2025 | EARNINGS
Mar 16, 2025 | INVESTING
Mar 16, 2025 | INVESTING